ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FAB Fusion Antibodies Plc

3.75
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Fusion Antibodies Investors - FAB

Fusion Antibodies Investors - FAB

Share Name Share Symbol Market Stock Type
Fusion Antibodies Plc FAB London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 3.75 08:00:04
Open Price Low Price High Price Close Price Previous Close
3.80 3.75 3.80 3.75 3.75
more quote information »
Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Top Investor Posts

Top Posts
Posted at 18/1/2024 08:02 by cyberbub
The CFO on the Investor Meets Company presentation did indeed say that cash was flat from September to October and that they had already paid out the redundancy payments from the downsizing.
Posted at 10/1/2024 18:13 by cumnor
Yea, question is does management really have the expertise and clout to sell the brand to big investors-not penny punters. Should be an easy sell in reality-even getting the NCI in the US to show a remote interest in their antibody library is some feat one typically underappreciated by gormless UK II analysts who don't know their ars..from their elbows, and confirms the science side of things is worthwhile.
Persuading IIs that a single antibody with prospects (look at GSKs deal for early phase 2 respiratory AB they paid a billion + for the right to develop-ex China-which hasn't even been approved for clinical use yet to give one an idea of the scale and potential here. I'm afraid mgmt don't seem up to it, especially if they have to resort to Proactive to sell the story for funds.
Posted at 26/12/2023 21:28 by gtc1508
hxxps://youtu.be/8y_ZZiRbP2k?feature=shared

Watch the investor presentation where CEO talks around this.

The NCI partnership is cash neutral but fusion have agreed NCI can retain the antibodies they are targeting.

Key thing is the company have agreed the limited set with the NCI, they can also work on these with clients and they are happy they have not lost anything.

The key thing for the company is the validation by the world leading research agency of their world first prototype technology. Aka if they are succcessul then the technology is proven at zero cost to fusion and will be highly attractive in the market and likely that NCI will wish to continue to use on a fee for use basis(or buyout) on the other side
Posted at 08/12/2023 10:06 by jaknife
luckyabbeygale,

Well done on making a quick profit on a scalp trade.

You appear to be referring to this post:



==================================
luckyabbeygale,

"I missed the rise and was worried the sells start coming again. Therefore I only bought 200 pp at 6p and now I wish I bought a lot more."

You'll get the chance to buy a lot more at a lot lower, the accounts note that they expect to place in Q1.

JakNife
==================================

This comment was based on the words in GDR's accounts:

"The Group and Company does not currently have sufficient cash resources to continue as a going concern during the forecast period due to the time expected to be needed to gain commercial traction in its revenues. Therefore, the Company will need to raise further equity, or other funding, in early 2024 in order to continue as a going concern. The forecasts prepared by the Directors include a plan to raise additional funds from equity investors or debt providers in early 2024 to allow the Company to continue as a going concern." [my bold]

see:

Q1 is a period of time that starts on 1 Jan 2024 and ends on 31 March 2024. I will entertain complaints about my post above at the end of Q1. In the meantime I wish you a joyous Christmas!

JakNife
Posted at 07/12/2023 13:04 by bones698
Must admit unless they manage to sign some decent deals they will be raising cash in the next few months for sure . Even with a big contract which hasn't arrived and is never guaranteed until it's signed the cash position is precarious and the longer they leave it and closer they get to running out of cash the worse the raise will be for investors ..
The mkt cap is minimal just over a million leaks anything decent could see this rocket but the odds of that are slim and it's this price for a reason.
I'll wait for news and financing before even thinking of investing here it's just very very high risk
Posted at 06/12/2023 17:18 by clocktower
LOL daniel - his warnings were spot on when the nasty Paul Warwick was trying desperately to shore up his position by ramping this and saying he was getting his friends to buy even when it bounced to 95p, as I think he must have swallowed hook sink and line what the previous Board of Directors feed him.

I never like to see Private Investors make losses but in his case I have no sympathy at all, due to his actions.

I have not followed it closely since they did the raise at the huge discount after the first profitable bounce, while warning this share is a dog.

Still if you to have taken the bait, I hope you will not get hurt if and when the hook bites.
Posted at 04/10/2023 10:10 by bobaxe1
Investor meet company at 11am
Posted at 01/8/2023 07:52 by soultrading
The rvr down here is very much in new investors favour. This has the potential to be huge from these levels
Posted at 19/5/2023 11:34 by timbo003
I see that the CFO has scarpered, not surprised really as he has been telling investors for the last couple of years that the company shouldn't require further funds to reach cash break even 😦
Posted at 30/7/2022 08:39 by whatsthepoint
Hi all this just shows you how corrupt and bent the market makers are.

And shows the madness of investors psyche. No one wanted to touch them at 35/40. And as soon as they go up 100% from there people wake up look to get some but the market makers turn off the electronic trading as they can’t supply the stock and don’t want to get caught short at the low levels they have driven it down to.

The market makers make it impossible to buy rush the price back up on tiny volume until they get to a level they happy to offload and as soon as the buying slows and a few sells come in they chop the legs of it.

This is a buy buy buy and hold hold hold. Not a trading share. I still have friends who are waiting to buy in as funds come available.

Market makers are so good at encouraging sellers by dropping the price day after day on no news.

Investors need to take advantage of the drops by the market makers and take the shares they offer when it drops.

The fundamentals of the business are sound and we are already told by the new CEO the potential is for significant value to be created. I am sure he can see a great chance to obtain options as Soon as he can and then strive to grow the business and create him and us all the significant value.

Not time to be shaken out. Now is the time to selectively accumulate ahead of the Optimal commercial launch next year.

And hopefully he encourages some promotion to new potential investors. Just look how hard it is to get stock when small demand arrives.

Your Recent History

Delayed Upgrade Clock